AU637657B2 - Co-polymer production - Google Patents
Co-polymer production Download PDFInfo
- Publication number
- AU637657B2 AU637657B2 AU67827/90A AU6782790A AU637657B2 AU 637657 B2 AU637657 B2 AU 637657B2 AU 67827/90 A AU67827/90 A AU 67827/90A AU 6782790 A AU6782790 A AU 6782790A AU 637657 B2 AU637657 B2 AU 637657B2
- Authority
- AU
- Australia
- Prior art keywords
- component
- bacterium
- growth
- monomer units
- substrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 229920001577 copolymer Polymers 0.000 title claims abstract description 57
- 238000004519 manufacturing process Methods 0.000 title claims description 15
- 241000894006 Bacteria Species 0.000 claims abstract description 55
- 239000000178 monomer Substances 0.000 claims abstract description 46
- 238000000034 method Methods 0.000 claims abstract description 38
- 241000252867 Cupriavidus metallidurans Species 0.000 claims abstract description 20
- 230000002906 microbiologic effect Effects 0.000 claims abstract description 5
- 239000000758 substrate Substances 0.000 claims description 34
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 229910052799 carbon Inorganic materials 0.000 claims description 17
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 16
- 239000012736 aqueous medium Substances 0.000 claims description 16
- 239000002609 medium Substances 0.000 claims description 13
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 235000015097 nutrients Nutrition 0.000 claims description 10
- 230000037353 metabolic pathway Effects 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 235000019260 propionic acid Nutrition 0.000 claims description 6
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 5
- 238000003306 harvesting Methods 0.000 claims description 5
- 239000011574 phosphorus Substances 0.000 claims description 5
- 229910052698 phosphorus Inorganic materials 0.000 claims description 5
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical group CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- SJZRECIVHVDYJC-UHFFFAOYSA-M 4-hydroxybutyrate Chemical compound OCCCC([O-])=O SJZRECIVHVDYJC-UHFFFAOYSA-M 0.000 abstract 1
- REKYPYSUBKSCAT-UHFFFAOYSA-N 3-hydroxypentanoic acid Chemical compound CCC(O)CC(O)=O REKYPYSUBKSCAT-UHFFFAOYSA-N 0.000 description 129
- WHBMMWSBFZVSSR-UHFFFAOYSA-N R3HBA Natural products CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 26
- WHBMMWSBFZVSSR-UHFFFAOYSA-M 3-hydroxybutyrate Chemical compound CC(O)CC([O-])=O WHBMMWSBFZVSSR-UHFFFAOYSA-M 0.000 description 24
- 238000009825 accumulation Methods 0.000 description 17
- 229920000331 Polyhydroxybutyrate Polymers 0.000 description 15
- 239000005015 poly(hydroxybutyrate) Substances 0.000 description 15
- 229920000642 polymer Polymers 0.000 description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 13
- 239000008103 glucose Substances 0.000 description 13
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 7
- 150000003839 salts Chemical class 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 6
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 229920001817 Agar Polymers 0.000 description 4
- 239000008272 agar Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- -1 acetyl thioester Chemical class 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 235000020774 essential nutrients Nutrition 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- 239000005864 Sulphur Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 2
- 239000005516 coenzyme A Substances 0.000 description 2
- 229940093530 coenzyme a Drugs 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000010924 continuous production Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 238000013048 microbiological method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- 231100000350 mutagenesis Toxicity 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- YNCMLFHHXWETLD-UHFFFAOYSA-N pyocyanin Chemical compound CN1C2=CC=CC=C2N=C2C1=CC=CC2=O YNCMLFHHXWETLD-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229920001791 ((R)-3-Hydroxybutanoyl)(n-2) Polymers 0.000 description 1
- XQONXPWVIZZJIL-UHFFFAOYSA-N 1-(4-chlorophenyl)cyclobutane-1-carbonitrile Chemical compound C1=CC(Cl)=CC=C1C1(C#N)CCC1 XQONXPWVIZZJIL-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- KUWPCJHYPSUOFW-YBXAARCKSA-N 2-nitrophenyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC=C1[N+]([O-])=O KUWPCJHYPSUOFW-YBXAARCKSA-N 0.000 description 1
- NVPCGXUWUBHZBD-UHFFFAOYSA-N 3-hydroxybut-2-enoic acid Chemical group CC(O)=CC(O)=O NVPCGXUWUBHZBD-UHFFFAOYSA-N 0.000 description 1
- QHHKKMYHDBRONY-RMNRSTNRSA-N 3-hydroxybutanoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 QHHKKMYHDBRONY-RMNRSTNRSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 101000755953 Bacillus subtilis (strain 168) Ribosome maturation factor RimP Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 description 1
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-J NADPH(4-) Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP([O-])(=O)OP([O-])(=O)OC[C@@H]2[C@H]([C@@H](OP([O-])([O-])=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-J 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 241000600898 Nocardia salmonicolor Species 0.000 description 1
- YJQPYGGHQPGBLI-UHFFFAOYSA-N Novobiocin Natural products O1C(C)(C)C(OC)C(OC(N)=O)C(O)C1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 108010093965 Polymyxin B Proteins 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- OJFDKHTZOUZBOS-CITAKDKDSA-N acetoacetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 OJFDKHTZOUZBOS-CITAKDKDSA-N 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- RIUKRCNLZYDWHS-UHFFFAOYSA-N ethane;methanesulfonic acid Chemical compound CC.CS(O)(=O)=O RIUKRCNLZYDWHS-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 231100000707 mutagenic chemical Toxicity 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- YJQPYGGHQPGBLI-KGSXXDOSSA-N novobiocin Chemical compound O1C(C)(C)[C@H](OC)[C@@H](OC(N)=O)[C@@H](O)[C@@H]1OC1=CC=C(C(O)=C(NC(=O)C=2C=C(CC=C(C)C)C(O)=CC=2)C(=O)O2)C2=C1C YJQPYGGHQPGBLI-KGSXXDOSSA-N 0.000 description 1
- 229960002950 novobiocin Drugs 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940056360 penicillin g Drugs 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000024 polymyxin B Polymers 0.000 description 1
- 229960005266 polymyxin b Drugs 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 102220277134 rs776745497 Human genes 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
- C12P7/625—Polyesters of hydroxy carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
- C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/829—Alcaligenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Polyesters Or Polycarbonates (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A microbiological process, and novel bacteria e.g. Alcaligenes eutrophus NCIMB 40124, for use in such a process. The process enables the more efficient prooduction of copolymers comprising hydroxyvalernate and hydroxybutyrate monomer units.
Description
AUSTRALIA
Patents Act 637657 COMPLETE SPECIFICATION
(ORIGINAL)
Class Int. Class Application Number: Lodged: Complete Specification Lodged: Accepted: Published: Priority Related Art:
S
SApplicant(s): Imperial Chemical Industries PLC Imperial Chemical House, Millbank, London SWlP 3JF, UNITED KINGDOM Address for Service is: PHILLIPS ORMONDE FITZPATRICK Patent and Trade Mark Attorneys 367 Collins Street Melbourne 3000 AUSTRALIA Complete Specification for the invention entitled: CO-POLYMER PRODUCTION Our
POF
Ref 200346 Code: 1453/1453 The following statement is a full description of this invention, including the best method of performing it known to applicant(s): 006 6006 If B 35544 Copolymer production This invention relates to a microbiological method of producing copolymers comprising 3-hydroxybutyrate (HB) monomer units and 3-hydroxyvalerate (HV) monomer units and to a new micro-organism suitably adapted for use in such a microbiological method.
Homopolymer consisting of HB monomer units, known as polyhydroxybutyrate (PHB) is accumulated by various micro-organisms, principally bacteria, as an energy reserve material as granules within the microbial cells.
PHB extracted from such cells is a thermo lastic 0 polyester of the repeat structure S.
-O.CH(CH
3
).CH
2
.CO-
that crystallises to a relatively high level e.g. of the order of 15 70% or more. This crystallisation behaviour is often disadvantageous when the polymer is to be used ao, for example, a moulding material.
It is known that the crystallisation of PHB may be modifiei by incorporation of units of a dissimilar monomer, into 20 the polymer chain and thereby forming a copolymer. Copolymers, comprising HB monomer units and a minor proportion of dissimilar units may be produced by the cultivation of certain micro-organisms, under certain conditions in the presence of certain acids, and alcohols.
Polymers exhibiting an infra-red band said to be indicative of ethylenic unsaturation are described by Davis in "Applied Microbiology" 12 (1964) pages 301 to 304. These polymers which are said by Davis to be copolymers containing 3-hydroxybutyrate units and 3-hydroxy-2-butenoate units, i.e.
units of the formula -O.C(CH3)=CH.COwere prepared by cultivating Nocardia on n-butane.
Wallen et al describe, in "Environmental Science and Technology" 6 (1972) pages 161 to 164 and 8 (1974) pages 576 to 579, a polymer melting at 97 to 100 0 C (after repeated washing) 2 B 35544 isolated from activated sludges and containing 3-hydroxybutyrate units and 3-hydroxyvalerate units, i.e.
-O.CH(C2H 5
).CH
2
.CO-
units in the ratio of Marchessault et al reported in "IUPAC Macro Florence 1980 International Symposium on Macromolecules Preprints" 2 (1980) pages 272 to 275 a study of this polymer and confirmed that it contained mainly 3-hydroxyvalerate units.
United States Patent Specification 3275610 describes the microbiol. ;ical production of polyesters by cultivating certain micro-organisms, especially Nocardia salmonicolor, on carboxylic *o* acids containing 4 carbon atoms.
European Patent Specification 0069497 describes the microbial production of a number of polyesters by cultivating 15 certain micro-organisms especially Alcaligenes eutrophus mutant NCIB 11599 on suitable substrates.
Published European Patent Application 0204442 describes the microbial production of copolymers of HB and HV by the cultivation of Alcaligenes eutrophus mutant NCIB 12080 on primary 20 alcohols having an odd number of carbon atoms, but excluding methanol.
In order to produce copolymers it known to be necessary to provide a substrate, i.e. a source of energy and carbon, comprising a component that is capable of giving rise to the dissimilar monomer units during at least part of the period when copolymer is accumulated. Thus, for example, in order to produce a copolymer, comprising HB monomer units and HV monomer units, the bacteria are required to be cultivated on a substrate comprising a component from which HV is capable of being synthesised, e.g.
propionic acid.
The component that gives rise to the HV monomer units within the copolymer is herein termed the HV component of the substrate.
Specific cultivation conditions are normally needed in order to induce PHE production, and accumulation, in known 3 B 35544 bacteria. Such specific cultivation conditions are also necessary to induce copolymer production, and accumulation.
Some known bacteria produce PHB constitutively, i.e. do not need to be cultivated under specific conditions in order to produce, and accumulate PHB. Nevertheless, unless the aforementioned specific cultivation conditions are employed, even those known strains which produce PHB constitutively may metabolise an HV component such that copolymer is not produced and accumulated.
Furthermore, even when specific cultivation conditions are used, such that copolymer production, and accumulation is induced in known bacteria, only a small proportion of the HV component is converted by the bacteria into HV monomer units.
Thus, the HV component may give rise to non-monomer material, or 15 may be used to synthesise HB monomer units for incorporation into the copolymer, even if the HV component is the sole substrate during the polymer accumulation stage. The metabolism of the HV component, so as to synthesise HB monomer units, may occur to such an extent that significantly less than half of the HV component is 20 converted into the required HV monomer units, and results in the production of copolymers having low percentage levels of HV monomer units.
*In order to ensure that at least some of the HV component is converted into the required HV monomer units, and that the required proportion of HV monomer units are present in *the ccpolymer, the bacteria are required to be provided with a large excess of the HV component.
The low conversion efficiency coupled with the relative high expense of the HV component results in a HB/HV copolymer synthesis route that is expensive.
Furthermore, the necessary presence of such a large excess of the HV component in the substrate presents severe problems with conventional microbial routes for copolymer synthesis in that a potentially toxic environment is generated within which the bacteria are required to be cultivated.
-4- We have found that by identifying a major metabolic pathway, for the conversion of HV component to HB monomer units, and by providing strains of bacteria wherein such a pathway is substantially eliminated, it is possible to devise a process in which copolymers are synthesised at high HV component to HV monomer unit conversion efficiencies.
Accordingly, we provide a microbiological process for the production of copolymers comprising HB and HV monomer units using a PHB accumulating bacterium having substantially no major metabolic pathway for the conversion of HV component to HB monomer units and which is not capable of significant growth when cultivated under otherwise non growth limiting conditions on a substrate consisting essentially of an HV component, which process comprises cultivating the bacterium in an aqueous medium in which the substrate comprises a water soluble assimilable carbon containing HV component and a water soluble assimilable carbon containing HB component, at a desired weight of dry cells per litre of medium under growth limitation conditions conducive to the bacterium synthesising and accumulating copolymer, and thereafter harvesting the copolymer containing bacterium.
We also provide a microbiological process for the production of copolymers comprising HB and HV monomer units using a PHB accumulating bacterium from which a major metabolic pathway for the conversion of HV component to HB monomer units has been substantially eliminated and which is not capable of significant growth when cultivated under otherwise non growth
I
*limiting conditions on a substrate consisting essentially of an 30 HV component, which process comprises cultivating the bacterium in an aqueous medium in which the substrate comprises a water soluble assimilable carbon containing HV component and a water soluble assimilable carbon containing HB component, at a desired weight of dry cells per litre of medium under growth limitation I .o35 conditions conducive to the bacterium synthesising and accumulating copolymer, and thereafter harvesting the copolymer containing bacterium.
"The process conditions under which the bacterium is.
The process conditions under which the bacterium is 4a cultivated, i.e. temperature, pH, aeration, essential nutrients, may be similar to those commonly used in PHB accumulation processes.
Those essential nutrients required for the growth of the bacterium comprise the following elements, which are normally present in readily assimilable form, normally as water soluble salts: nitrogen, phosphorus, sulphur, potassium, sodium, magnesium, calcium, and iron, together with traces of manganese, zinc and copper.
At least part of the cultivation is conducted under growth limitation conditions, i.e. under conditions wherein an essential requirement for growth but not copolymer accumulation is limited. Under such growth limitation conditions the tendency of the bacterium to produce and accumulate PHB homopolymer is avoided, and the production and accumulation of HV containing e.
O* 0 ft .o *o o *ooo• ."30 *o B 35544 polymer is induced. Whilst it may be possible to induce copolymer accumulation by restricting the supply of oxygen to the bacterium, it is preferred to restrict the supply of one or more of the essential nutrients. The most practical elements to limit are nitrogen, phosphorus, or, less preferably, magnesium, sulphur or potassium. The nitrogen may be conveniently supplied in the form of an ammonium salt, whereas the phosphorus may be conveniently supplied as a phosphate.
Where nitrogen limitation is employed, the substrate is preferably nitrogen free and so amide derivatives of the HV componet a less preferred. The amount of assimilable nitrogen required ii about 10 to 15% by weight of the desired weight of cells less the weight of the accumulated copolymer.
S" Similar considerations apply, where phosphorus *15 limitation is employed.
Cultivation of the bacterium is preferably conducted so that the dry weight of the copolymer-containing cells is at least g.1 1 preferably at least 80 g.l 1, and particularly at least 120 g.l 1 *to. 20 The bacterium used is capable of efficiently converting the HV component present in the substrate to HV monomer units.
Specifically the bacterium can convert the HV component to HV monomer units at an efficiency, on a molar basis, of greater than 45%, particularly at least 60%, and especially between 70 and and further advantageously between 80 and V. Preferably, those conditions under which a specific bacterium should be cultivated are those which maximise the efficiency of conversion.
Cultivation of the bacterium preferably comprises a two stage process. In the first stage the bacterium is preferably grown to a certain dry weight per litre, under non-growth limiting conditions on a readily metabolisable substrate, such as a carbohydrate, for example glucose. In the second stage the substrate is at least in part the HV component, and at least one nutrient required for growth is limited, such that the growth 6 B 35544 limiting conditions exist.
The cultivation may be performed as a batch process, such that copolymer accumulation will occur as the amount of the nutrient required for growth but not copolymer accumulation becomes depleted.
Alternatively, the cultivation may be performed as a continuous process, wherein a stream of culture is removed from the vessel, in which the bacterium is being cultivated, on a continuous or semi continuous basis. The stream removed from the vessel contains bacterium cells in a spent aqueous medium. The spent aqueous medium comprises residual quantities of nutrients 6 too and substrate. The flowrate of the stream leaving the vessel corresponds to the rate of addition of fresh aqueous medium to the o ."vessel. The fresh aqueous medium supplied to the vessel contains
V,
15 nutrients and substrate in sufficient amounts to support "accumulation of uopolymer. Preferably the amount of that nutrient, used to limit the growth of the bacterium, which is fed to the vessel is such that little or none of that nutrient is present in the spent aqueous medium removed from the vessel.
9949 Further, it is preferred that the spent aqueous medium is fed to at least one further aerated cultivation stage under batch or C. 9 preferably continuous or semi-continuous operation, wherein additional copolymer accumulation is stimulated by the addition of fresh HV component containing substrate to the spent aqueous medium. The levels of nutrients and substrate may be adjusted in :Q the spent aqueous medium after leaving the first cultivation stage such that optimum operation of the overall process is maintained.
Alternatively, the cultivation of the bacterium may be conducted as a single stage process. In such a process, wherein copolymer accumulation is induced by limiting the amount of a nutrient required for growth but not for copolymer accumulation, the residence time of the aqueous medium in the vessel is made sufficiently long so as to allow exhaustion of the limiting nutrient, and for copolymer accumulation to occur.
In either a single or multistage process, or in batch or 7 B 35544 semi continuous or continuous process the HV component may be present as the sole source of carbon present in the substrate during all, or part of, the copolymer accumulation stage, or may be in admixture with other assimilable carbon sources.
The concentration of the HV component in the aqueous medium depends on a number of factors, e.g. whether the process is batch or continuous, the percentage copolymer desired, the percentage of HV monomer units in the copolymer desired. Because the bacterium used is capable of synthesising and accumulating copolymer at high conversion efficiencies, the concentration of •Y the HV component in the medium to, and hence medium from, the process is relatively low. Generally, the concentration of the HV component at the point of harvest of the bacterium is preferably between 0.1 and 25, and particularly between 5 and 10 g.1 15 The HV component may be propanol, propionic acid, or a salt, ester, anhydride, amide, or halide thereof.
Mixtures of compounds suitable for use as HV components may be used.
It is believed that the high conversion of HV component 20 to HV monomer units is made possible because the bacterium cultivated is no longer able to metabolise the HV component to acetyl CoA to a substantial extent.
Although we do not wish to be bound by the following theory, it is thought that the metabolic pathway leading to copolymers comprising HB monomer units and HV monomer units is as follows, in which CoA.SH is unesterified Coenzyme A,
CH
3 .CO.S.CoA is the acetyl thioester of Coenzyme A and is more commonly termed acetyl CoA, NADP is nicotinamide adenine dinucleotide phosphate in the oxidised state, and
NADPH
2 is reduced NADP.
It is believed that, in the biosynthesis of PHB by a micro-organism, the first step is the synthesis of acetyl CoA.
This can be formed for example, from CoA and acetate, or by the 8 B 35544 decarboxylation of pyruvate, which is the product of the glycolysis of carbohydrates, or which can be formed by decarhoxylation. of oxaloacetate, the latter being a member of the tricarboxylic acid (TCA) cycle, otherwise known as the Krebbs cycle.
Thus with acetate as the source of acetyl CoA, the PHB is produced by a metabolic pathway involving the reactions: 1. CH 3 .CO.O CoA.SH thiokinase CH 3 .CO.S.CoA OH 2. 2CH 3 .CO.S.CoA B ketothiolase GH 3
*CO.CH
2 .GO.S.CoA CoA.SH 3. GH 3
.GO.GH
2 *CO.S.CoA reductase CH 3
.CHOH.GH
2 .CO.S.CoA o NADPH 2
NADF
a 4. CH 3 .CHOH.C11 2 .CO.S.CoA polymerase- O.CH(CH 3
).GH
2 .CO CoA.SH 15 wherein
H
3
,GO.CH
2 .CO.S.CoA is acetoacetyl CoA,
CH
3
,CHOH.CH
2 .CO.S.CoA is 3 hydroxybutyryl CoA and
O.CH(CH
3
).GH
2 *GO Is a repeat unit in the polymer.
Thus reaction 4 adds O.GH(CH 3
).GH
2 *CO -to a growing So 20 polymer chain.
~:.Because of a lack of specificity of the enzymes involved, the correspording pathway with, for example propionic acid, is thought to be: @00990 Ia. CH 3
.CH
2 .C -c CoA.SH thiokinase- CH 3
.CH
2 .CO.S.GoA
OH-
2a. CH 3
,CH
2 ,CO.S.CoA B ketothiolase- ~CH 3
.CH
2
.GO.CH
2 .CO.S.CoA
CH
3 ,CO.S.GoA CoA.SH 3a. NADPH 2 reductase--> NADP
C
3 .C1 2
CO.CH
2 .CO.S.CoA 0H 3
,CH
2
.CHOH.CH
2 .CO.S.CoA 4a. CH 3
.CH
2
.CRH.GH
2 .CO.S.GoA polymerase--'-O.CH(C 2
H
5 ).11 2 .c0 CoA.SH wherein
CH
3
*CH
2 .GO.S.CoA is propionyl GoA,
CH
3
.GH
2 .CO.G11 2 .CO.SoCoA is 3 ketovaleryl CoA,
CH
3
-CH
2 oCHOH.CH 2 -CO-S.CoA is 3 hydroxyvaleryl CoA and 9 B 35544
O.CH(C
2 H5).CH2.CO is a repeat unit in the polymer.
Thus reaction 4 a adds O.CH(C 2
H
5
).CH
2 .CO to a growing polymer chain.
As hereinbefore postulated one of the intermediates in the synthesis of an HB monomer unit is itself an intermediate in the synthesis of an HV, it is therefore preferred that the substrate comprises not only an HV component but also a carbon source metabolisable to the required HB monomer intermediate, i.e.
an HB component. Thus by controlling the relative amounts in the substrate of components for HB and HV synthesis it is possible to obtain copolymers containing varying proportions of HB and HV monomer units.
A bacterium suitably adapted for use in the process of the present invention may be produced by the mutation of a PHB g* 15 accumulating strain of Alcaligenes eutrophus, and by screening and selecting of the resultant mutants.
Accordingly, we further provide a strain, in particular as a pure culture, of Alcaligenes eutrophus designated NCIMB 40124, and mutants and variants derived therefrom.
20 The strain Alcaligenes eutrophus NCIMB 40124 was deposited at the National Collections of Industrial and Marine Bacteria Ltd. (NCIMB), PO Box 31, 135 Abbey Road, Aberdeen AB9 8DG, United Kingdom on the 24 March 1989, under the terms and conditions of the Budapest Treaty.
The strain Alcaligenes eutrophus NCIMB 40124, and useful mutants and variants derived therefrom, may be characterised by the following taxonomic description. The strain, and mutants and variants derived therefrom are able to produce and accumulate PHB in a manner similar to that of the parent strain NCIB 12080, produce and accumulate copolymers containing HB and HV monomer units at high HV component to HV monomer conversion efficiencies, grow on a substrate consisting of acetate, but show no grow on a substrate consising of propionate. The combination of these growth, no growth, and polymer accumulation characteristics distinguish the new strains of Alcaligenes eutrophus from existing B 35544 strains of Alcaligenes eutrophus. The evaluation of the growth/no growth characteristics, mentioned above, were conducted under non growth limiting conditions, on substrate having a carbon content which was provided essentially by the material under test, i.e.
acetate or propionate.
Description of Alcaligenes eutrophus NCIMB 40124.
Morphology Gram negative motile rods of approximate size 0.8 ym x pm.
Evidence of intra cellular granules.
No spore formation.
Under a phase contrast microscope occasional subpolar flagella are noted.
Colonial morphology (Lab 8 Nutrient Agar) the organism 15 is in the form of round, regular, opaque, smooth, white convex colonies. After 3 days the diameter was about 2 mm.
A pale brown pigmentation developed with increasing age.
Temperature 20 At 5 0 C no growth.
At 37 0 C growth.
At 45 0 C no growth.
Characteristics Catalase Kovacs Oxidase 0-F Glucose very weakly oxidative Pyocyanin Fluorescence L-Arginine CSU Betaine CSU Glucose CSU Lactate CSU Acetate CSU CSU Arabinose Meso-inositol 11 B 35544 Xylose Gas Glucose
ONPG
Arginine Moller Lysine Moller Ornithine Moller
NO
3 to NO 2
NO
3 to N 2 at 37 0
C
DNA ase Gel stab.
Gel plate Casein Starch Lecithin egg 15 Lipase egg
NH
3 weakly positive Indole
H
2
S
Tween 80 20 Urease No growth exhibited on methanol at 5 or 14 days.
No growth exhibited on propan-1-ol at 5 or 14 days.
Growth exhibited on acetate at 3 days.
Resistant to penicillin G and stretomycin.
Sensitive to chloramphenicol, tetracycline, polymyxin B and novobiocin (weakly).
Strains of Alcaligenes eutrophus in accordance with the present invention may be produced in a variety of ways, for example, transposon mutagenesis including excision of inserted transposons which are able to cause deletions, chemical mutagenesis using mutagens such as ethane methane sulphonate and mutations caused by invitro manipulation and subsequent recombination.
Strain Alcaligenes eutrophus NCIMB 40124 was prepared in the following manner.
12 B 35544 The parent culture was Alcaligenes eutrophus NCIB 12080, available from the National Collection of Industrial and Marine Bacteria Ltd under the terms and conditions of the Budapest Treaty.
The parent culture was grown in mineral salts medium, plus glucose at to an optical density of 0.9, as measured at 600nm. A sample (10 mis) of the culture, as grown, was transferred to a 9 cm glass petri dish, and then irradiated with UV light at a dose level sufficient to achieve a kill of 99.9%.
The irradiated culture was transferred to a flask containing mineral salts medium, plus glucose at and o incubated, at 30 0 C, in the dark for about 16 hours.
10 mis of the incubated culture were then transferred to a flask containing mineral salts medium, plus sodium propionate at 15 0.075% and D-cycloserine at 800 pg.ml The contents of the flask were then incubated, at 30 0 C, for about 16 hours.
The culture was then centrifuged, and the resulting pellet resuspended in sterile distilled water.
Serial dilutions were made from the suspension and 20 0.1 ml aliquots plated from the dilutions onto mineral salts agar containing glucose at The plates were then incubated and the resulting colonies were replicated plated onto mineral salts agar, containing propionate at 0.075%.
Colonies were identified that were able to grow on the 0 S glucose agar plates but not the propionate agar plates. These S*0 colonies were selected for further investigation.
The selected colonies of putative mutants were screened for their ability to grow using glucose, or acetate, as a carbon source; their inability to grow on propionate; and their ability to produce and accumulate copolymer, comprising HB monomer and HV monomer units, when supplied with glucose and propionate under nitrogen limited conditions.
One strain produced according to the hereinbefore described procedure is Alcaligenes eutrophus NCIMB 40124.
The process of the present invention is illustrated by 13 B 35544 the following examples.
EXAMPLE 1 An aqueous medium containing the following, expressed as and having a pB of about 7 (controlled by ammonia addition) was prepared.
MgSO 4 .7H 2 0 2.2
K
2 S0 4 Na 2
SO
4 0.18 FeSO 4 .7H 2 0 0.18 Glucose 13.0 Trace elements 3.0 (m]s) S" Phosphoric Acid 6.5 (mls of 1.1 M) A fermenter containing 31 of the above medium was inoculated with a starter culture of Alcaligenes eutrophus NCIMB 15 40124. The inoculated medium was incubated, at 30 0 C, for 24 hours a ,e until the phosphate content of the medium became limiting.
a a Glucose, and propionic acid were chen fed to the fermenter at rates of 10 g.hr-1, and 3.3 g.hr-1 respectively, for a further 48 hours.
20 The cells containing the copolymer were harvested, freeze dried, and analysed for polymer content and composition.
0 1 EXAMPLE 2 Example 1 was repeated, except that the flow rates of the glucose and the propionic acid were 6.4 g.hr and 0.7 -1 g.hr respectively.
COMPARATIVE EXAMPLE 3 Example 1 was repeated, except strain Alcaligenes eutrophus NCIB 12080, was used instead of strain Alcaligenes eutrophus NCIMB 40124.
COMPARATIVE EXAMPLE 4 Example 2 was repeated, except strain Alcaligenes eutrophus NC1B 12080, was used instead of strain Alcaligenes eutrophus NCIMB 40124.
The results of Examples 1 to 4 were as folloas: B 35544 I Example I% HV Component I Conversion I I of I In Feed E n Copolymer I HV Component I 11 33 1 29 I88 2 11 U 7 64 C3 33 10 I I C4 I11 I5 It can thus be seen that the process of the present invention, employing a bacterium according to the invention, can give rise to substantial increase in the conversion efficiency of an 1W component into HV monomer units.
we I C CO.
9.
3 *d
C
CC
Ci
I.
.8 CCC
AC
9 9 CC CO.
B
CCC 4
CCBC
C
CC C
C'
4*
CCI
PA/EJN/JWR/MP
22 November 1990/P15A
Claims (13)
1. A microbiological process for the production of copolymers comprising HB and HV monomer units using a PHB accumulating bacterium having substantially no major metabolic pathway for the conversion of HV component to HB monomer units and which is not capable of significant growth when cultivated under otherwise non growth limiting conditions on a substrate consisting essentially of an HV component, which process comprises cultivating the bacterium in an aqueous medium in which the substrate comprises a water soluble assimilable carbon containing HV component and a water soluble assimilable carbon containing HB component, at a desired weight of dry cells per litre of medium under growth limitation conditions conducive to the bacterium synthesising and accumulating copolymer, and thereafter harvesting the copolymer containing bacterium.
2. A microbiological process for the production of copolymers comprising HB and HV monomer units using a PHB accumulating bacterium from which a mFjor metabolic pathway for the conversion of HV component to HB monomer units has been substantially eliminated and which is not capable of significant growth when cultivated under otherwise ion growth limiting conditions on a substrate consisting essentially of an HV component, which process comprises cultivating the bacterium in an aqueous medium in which the substrate comprises a water soluble assimilable carbon containing HV component and a water soluble assimilable carbon containing HB component, at a desired weight of dry cellu per litre of medium under growth limitation conditions conducive to the bacterium synthesising and accumulating copolymer, and thereafter harvesting the copolymer containing bacterium.
3. A process as claimed in claim 1 or 2 wherein the 3: 5 bacterium is capable of converting more than 45% of the HV component present in the substrate into HV monomer units. 000
4. A process as claimed in any one of claims I to 3 wherein the concentration of the HV component in the aqueous medium is V-x 16 controlled in order to achieve a desired percentage of HV monomer units in the copolymer.
A process as claimed in any one of claims 1 to 4 wherein the concentration of the HV component in the medium associated with the harvested bacterium is between 0.1 and 25 g.1l
6. A process as claimed in any one of zlaims 1 to 5 wherein the HV component is propanol, propionic acid, or an assimilable derivative thereof.
7, A process as claimed in any one of claims 1 to 6 wherein the cultivation of the bacterium is conducted so that the dry weight of the copolymer containing cells is at least 30 g.l-
8. A process as claimed in any one of claims 1 to 7 wherein the cultivation of the bacterium comprises a two stage process, such that in a first stage the bacterium is grown to the desired dry weight per litre, under non growth limiting conditions on a readily metabolisable substrate and in a second stage the substrate is at least in part the HV component, and at least one nutrient required for growth is limited, such that the growth limiting conditions exist.
9. A process as claimed in any one of claims 1 to 8 wherein the growth limitation conditions are achieved by limiting the amount of assimilable nitrogen and/or phosphorus availa'.e.
A process as claimed in claim 9 wherein the amount of S.*0 assimilable nitrogen available is about 10 to 15% by weight of the desired weight of cells less the weight of the accumulated copolymer.
11. Alcaligenes eutrophus strain NCIMB 40124, or mutan.ts or variants thereof wherein the mutants or variants are not capable Sof significant growth when cultivated under non growth limiting conditions on a substrate having a water soluble carbon content, "e and the water soluble carbon content is provided essentially by San HV component. D'^ 17
12. A process for producing a PHB accumulating bacterium whicn is capable of producing copolymers comprising HB and HV units from a substrate comprising HB and HV components which has no major metabolic pathway for the conversion of HV component to HB monomer units and which is not capable of significant growth when cultivated under otherwise non growth limiting conditions on a substrate consisting essentially of an HV component which process comprises substantially eliminating a major metabolic pathway for the conversion of HV component to HB monomer units from a PHB accumulating bacterium.
13. A process, as claimed in claim 1, substantially as hereinbefore described with reference to any one of the examples. DATED: 22 March 1993 PHILLIPS ORMONDE FITZPATRICK Attorneys for: 04c7dt P IMPERIAL CHEMICAL INDUSTRIES PLC 2464N DO go *S
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8927794 | 1989-12-08 | ||
GB898927794A GB8927794D0 (en) | 1989-12-08 | 1989-12-08 | Copolymer production |
Publications (2)
Publication Number | Publication Date |
---|---|
AU6782790A AU6782790A (en) | 1991-06-13 |
AU637657B2 true AU637657B2 (en) | 1993-06-03 |
Family
ID=10667644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU67827/90A Ceased AU637657B2 (en) | 1989-12-08 | 1990-12-07 | Co-polymer production |
Country Status (13)
Country | Link |
---|---|
US (1) | US5364778A (en) |
EP (1) | EP0431883B1 (en) |
JP (1) | JP3036851B2 (en) |
KR (1) | KR100223341B1 (en) |
AT (1) | ATE149204T1 (en) |
AU (1) | AU637657B2 (en) |
BR (1) | BR9006231A (en) |
CA (1) | CA2031888C (en) |
DE (1) | DE69029993T2 (en) |
GB (2) | GB8927794D0 (en) |
IN (1) | IN177461B (en) |
NZ (1) | NZ236394A (en) |
ZA (1) | ZA909816B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU652942B2 (en) * | 1990-05-25 | 1994-09-15 | Monsanto Company | HV/HB copolymer production |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2061405B1 (en) * | 1993-05-04 | 1995-11-01 | Univ Granada | PRODUCTION OF POLYHYDROXIALCANOATES (PHAS) BY AZOTOBACTER CHROOCOCCUM PHA. |
GB9419082D0 (en) * | 1994-09-22 | 1994-11-09 | Zeneca Ltd | Copolyesters |
WO1997022711A1 (en) | 1995-12-19 | 1997-06-26 | Regents Of The University Of Minnesota | Metabolic engineering of polyhydroxyalkanoate monomer synthases |
MXPA00009561A (en) | 1998-03-30 | 2002-08-06 | Metabolix Inc | Microbial strains and processes for the manufacture of biomaterials. |
AU750835B2 (en) * | 1999-05-12 | 2002-08-01 | Metabolix, Inc. | Methods for purifying polyhydroxyalkanoates |
US6225438B1 (en) | 2000-01-31 | 2001-05-01 | The Procter & Gamble Company | Medium chain length PHA copolymer and process for producing same |
EP1951875A2 (en) * | 2005-09-08 | 2008-08-06 | Meredian, Inc. | Deregulated bacteria with improved polyhydroxyalkanoate production |
MX363097B (en) | 2011-10-25 | 2019-03-08 | Marrone Bio Innovations Inc | Chromobacterium formulations, compostions, metabolites and their uses. |
AU2011381254B2 (en) | 2011-11-17 | 2016-05-19 | Bio On S.R.L. | Process for producing microbial copolyesters from sucrose-containing feedstocks |
RU2484140C1 (en) * | 2011-12-26 | 2013-06-10 | Федеральное Государственное Автономное Образовательное Учреждение Высшего Профессионального Образования "Сибирский Федеральный Университет" | Method of producing copolymer of 3-hydroxybutyric acid and 3-hydroxyvaleric acid |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU560653B2 (en) * | 1981-07-07 | 1987-04-16 | Monsanto Company | 3-hydroxybutyrate polymers |
EP0288908A2 (en) * | 1987-04-28 | 1988-11-02 | Mitsubishi Gas Chemical Company, Inc. | Process for production of a random copolymer comprising D-(-)-3-hydroxybutyrate units and D-(-)-3-hydroxyvalerate |
AU601681B2 (en) * | 1985-05-28 | 1990-09-20 | Monsanto Company | Poly beta-hydroxybutyric acid/poly beta-hydroxyvaleric acid copolymer production |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3171017D1 (en) * | 1980-08-19 | 1985-07-25 | Ici Plc | Fermentation process |
EP0052459B1 (en) * | 1980-11-18 | 1985-12-04 | Imperial Chemical Industries Plc | Beta-hydroxybutyrate polymers |
US4477654A (en) * | 1981-07-07 | 1984-10-16 | Imperial Chemical Industries Plc | 3-Hydroxybutyrate polymers |
GB8311677D0 (en) * | 1983-04-28 | 1983-06-02 | Ici Plc | Extraction process |
US4788979A (en) * | 1986-09-23 | 1988-12-06 | American Cyanamid Company | Bioabsorbable coating for a surgical article |
CA1313158C (en) * | 1988-11-07 | 1993-01-26 | William J. Page | Hyperproduction of poly-.beta.-hydroxybutyrate during exponential growthby mutant strains of azotobacter vinelandii |
-
1989
- 1989-12-08 GB GB898927794A patent/GB8927794D0/en active Pending
-
1990
- 1990-12-03 GB GB909026238A patent/GB9026238D0/en active Pending
- 1990-12-04 AT AT90313133T patent/ATE149204T1/en not_active IP Right Cessation
- 1990-12-04 EP EP90313133A patent/EP0431883B1/en not_active Expired - Lifetime
- 1990-12-04 DE DE69029993T patent/DE69029993T2/en not_active Expired - Fee Related
- 1990-12-06 ZA ZA909816A patent/ZA909816B/en unknown
- 1990-12-06 IN IN1235DE1990 patent/IN177461B/en unknown
- 1990-12-07 JP JP2400947A patent/JP3036851B2/en not_active Expired - Lifetime
- 1990-12-07 BR BR909006231A patent/BR9006231A/en not_active IP Right Cessation
- 1990-12-07 NZ NZ236394A patent/NZ236394A/en unknown
- 1990-12-07 AU AU67827/90A patent/AU637657B2/en not_active Ceased
- 1990-12-08 KR KR1019900020175A patent/KR100223341B1/en not_active IP Right Cessation
- 1990-12-10 CA CA002031888A patent/CA2031888C/en not_active Expired - Fee Related
-
1993
- 1993-08-09 US US08/103,155 patent/US5364778A/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU560653B2 (en) * | 1981-07-07 | 1987-04-16 | Monsanto Company | 3-hydroxybutyrate polymers |
AU601681B2 (en) * | 1985-05-28 | 1990-09-20 | Monsanto Company | Poly beta-hydroxybutyric acid/poly beta-hydroxyvaleric acid copolymer production |
EP0288908A2 (en) * | 1987-04-28 | 1988-11-02 | Mitsubishi Gas Chemical Company, Inc. | Process for production of a random copolymer comprising D-(-)-3-hydroxybutyrate units and D-(-)-3-hydroxyvalerate |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU652942B2 (en) * | 1990-05-25 | 1994-09-15 | Monsanto Company | HV/HB copolymer production |
Also Published As
Publication number | Publication date |
---|---|
CA2031888C (en) | 2000-05-09 |
CA2031888A1 (en) | 1991-06-09 |
EP0431883B1 (en) | 1997-02-26 |
US5364778A (en) | 1994-11-15 |
EP0431883A3 (en) | 1991-11-06 |
IN177461B (en) | 1997-01-18 |
BR9006231A (en) | 1991-09-24 |
EP0431883A2 (en) | 1991-06-12 |
JPH05236973A (en) | 1993-09-17 |
GB9026238D0 (en) | 1991-01-16 |
ZA909816B (en) | 1991-11-27 |
KR910012251A (en) | 1991-08-07 |
KR100223341B1 (en) | 1999-10-15 |
ATE149204T1 (en) | 1997-03-15 |
DE69029993D1 (en) | 1997-04-03 |
AU6782790A (en) | 1991-06-13 |
GB8927794D0 (en) | 1990-02-14 |
DE69029993T2 (en) | 1997-07-10 |
NZ236394A (en) | 1993-04-28 |
JP3036851B2 (en) | 2000-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4477654A (en) | 3-Hydroxybutyrate polymers | |
EP0069497B1 (en) | Copolyesters and process for their production | |
JP2006204255A (en) | ACETYL-CoA ACYLTRANSFERASE GENE-BROKEN POLYHYDROXYALKANOATE-PRODUCING MICROORGANISM, AND METHOD FOR PRODUCING POLYHYDROXYALKANOATE THEREWITH | |
US7235396B2 (en) | Bacterium for producing polyhydroxyalkanoate having polyhydroxyalkanoate depolymerase gene disrupted and method for producing polyhydroxyalkanoate using the same | |
JP2918286B2 (en) | Production method of copolymer | |
AU637657B2 (en) | Co-polymer production | |
JPH0615604B2 (en) | β-hydroxybutyrate copolymer | |
JPH0515383A (en) | Plastic material consisting of beta- hydroxybutylate copolymer and method for forming the same | |
JP2006204257A (en) | Isogenic strain of polyhydroxyalkanoate synthetase gene-disrupted polyhydroxyalkanoate-producing microorganism, and method for producing polyhydroxyalkanoate therewith | |
CA1168999A (en) | Method for preparing 2,5-diketo-d-gluconic acid | |
EP2492348A1 (en) | Process for producing D-lactic acid from glycerol employing Pseudomonas auricularis, Pseudomonas azotoformans, Pseudomonas chlororaphis, Pseudomonas taetrolens, or Pseuomonas sp. | |
JPH057492A (en) | Production of copolymer | |
CN117701486B (en) | Recombinant bacterium for producing PHA and construction method and application thereof | |
US5387513A (en) | Microbiological production of polyesters having C8 and/or C10 monomer repeat units | |
KR100957772B1 (en) | Mutants Having a Producing Ability of 4?hydroxybutyrate and Method for Preparing 4HB Using the Same | |
SU1375143A3 (en) | Method of producing polymer containing monomeric units o. ch(ch sub three) ch sub two co | |
JP2002253285A (en) | Method for producing polyhydroxyalkanoate | |
US5264546A (en) | Copolymer production | |
CN117701488B (en) | Recombinant bacterium for producing PHA and method for improving PHA yield | |
CN118048246A (en) | Recombinant eutrophic bacteria for producing PHA (polyhydroxyalkanoate), and construction method and application thereof | |
WO1994009146A1 (en) | Phb-producing microorganism and process for removing clycerol from a culture medium |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Assignment registered |
Owner name: METABOLIX, INC. Free format text: FORMER OWNER WAS: MONSANTO COMPANY |
|
PC | Assignment registered |
Owner name: METABOLIX INC. Free format text: FORMER OWNER WAS: METABOLIX, INC. |